Extracorporeal Membrane Oxygenation Market : Global Industry Analysis and Opportunity Assessment, 2036

Buy Now

Extracorporeal Membrane Oxygenation Market is segmented by Modality (Venoarterial, Veno-venous, Arterio-venous), Application (Cardiac, Respiratory, Extracorporeal cardiopulmonary resuscitation (ECPR)), Patient Population (Adult, Infant, Pediatric), and Region. Forecast for 2026 to 2036.

  • Market Size (2026): USD 551.5 Mn
  • Forecast (2036): USD 741.1 Mn
  • CAGR (2026 to 2036): 3.0%
Methodology

Extracorporeal Membrane Oxygenation Market Size, Market Forecast and Outlook By FMI

The extracorporeal membrane oxygenation market was valued at USD 535.4 million in 2025. The market is set to reach USD 551.5 million by 2026-end and grow at a CAGR of 3.0% between 2026-2036 to reach USD 741.1 million by 2036. Venoarterial will dominate with a 47.8% share, while Cardiac will lead with a 42.1% share.

Summary of the Extracorporeal Membrane Oxygenation Market

  • Demand and Growth Drivers
    • Expanding end-use applications and growing adoption across key verticals are supporting demand growth for extracorporeal membrane oxygenation products during the forecast period.
    • Regulatory and compliance requirements are creating structured procurement demand as organizations upgrade to products that meet updated standards and specifications.
    • Geographic expansion into high-growth markets is creating new demand as infrastructure investment and economic development support increased consumption.
  • Product and Segment View
    • Venoarterial accounts for 47.8% of the Modality segment in 2026, supported by strong demand from primary end-use categories.
    • Cardiac represents 42.1% of the Application segment, reflecting mature adoption across key deployment scenarios.
    • Adult accounts for 56.4% of the Patient Population segment, reflecting demand concentration among primary buyer categories.
  • Geography and Competitive Outlook
    • China leads country-level growth at 4.1%, supported by infrastructure expansion and growing adoption across key verticals.
    • Europe remains the largest regional market, with demand from enterprises and institutional buyers.
    • Getinge AB leads at an estimated 19.0% market share, supported by production scale and established supply agreements.
  • Analyst Opinion
    • The extracorporeal membrane oxygenation market is transitioning from a traditional procurement category into a more established industrial supply segment as adoption accelerates across primary end-use environments.
    • Adoption is shaped by the convergence of regulatory requirements, infrastructure investment, and the operational need for improved performance and efficiency.
    • Pricing pressure from institutional buyers and procurement consolidation is compressing margins, shifting competitive differentiation toward product performance, service reliability, and total cost of ownership.
    • Companies that can deliver validated performance, competitive pricing, and reliable supply are positioned to capture growing procurement volume during the forecast period.

Extracorporeal Membrane Oxygenation Market Value Analysis

Extracorporeal Membrane Oxygenation Market Definition

The extracorporeal membrane oxygenation market includes all commercially traded extracorporeal membrane oxygenation products categorized by modality (venoarterial, veno-venous, arterio-venous), by application (cardiac, respiratory, extracorporeal cardiopulmonary resuscitation (ecpr)), by patient population (adult, infant, pediatric). Products are deployed across industrial, commercial, and institutional end-use environments.

Extracorporeal Membrane Oxygenation Market Inclusions

Market scope covers all commercially traded extracorporeal membrane oxygenation products categorized by modality (venoarterial, veno-venous, arterio-venous), by application (cardiac, respiratory, extracorporeal cardiopulmonary resuscitation (ecpr)), by patient population (adult, infant, pediatric). Revenue is tracked from 2026 to 2036.

Extracorporeal Membrane Oxygenation Market Exclusions

The scope does not include general-purpose products or solutions unrelated to the specific extracorporeal membrane oxygenation product category, or components sold as raw materials without end-use specification.

Extracorporeal Membrane Oxygenation Market Research Methodology

  • Primary Research: Interviews with industry practitioners, procurement decision-makers, and product manufacturers across key markets in North America, Europe, and East Asia.
  • Desk Research: Analysis of industry production data, regulatory standards, trade statistics, and published market intelligence.
  • Market Sizing and Forecasting: Bottom-up aggregation from end-use consumption and procurement data across primary segment and geographic categories, with regional adoption curves.
  • Data Validation: Cross-checked quarterly against industry production statistics, trade data, and manufacturer reports.

Why is the Extracorporeal Membrane Oxygenation Market Growing?

  • Expanding end-use applications and growing adoption across key verticals are supporting demand growth for extracorporeal membrane oxygenation products during the forecast period.
  • Regulatory and compliance requirements are creating structured procurement demand as organizations upgrade to products that meet updated standards and specifications.
  • China leads with 4.1% growth, reflecting infrastructure expansion and growing adoption of specialized solutions.

End-Use Demand and Application Growth

Demand for extracorporeal membrane oxygenation products reflects the structural shift in procurement patterns as organizations modernize infrastructure and expand operational capacity. Expanding end-use applications and growing adoption across key verticals are supporting demand growth for extracorporeal membrane oxygenation products during the forecast period. Adoption is supported by demonstrated performance advantages, favorable total cost of ownership calculations, and growing familiarity among procurement decision-makers.

Market Access and Distribution

Geographic expansion into high-growth markets is creating new demand as infrastructure investment and economic development support increased consumption. Regulatory compliance requirements are creating a structured demand floor that grows with the expanding scope of applicable standards and specifications.

Supply Chain and Pricing Dynamics

Price sensitivity among buyers and competition from alternative solutions constrain growth in cost-driven segments. Procurement consolidation among large institutional buyers is creating competitive pressure on pricing, while manufacturers focus on product differentiation, service quality, and supply reliability to maintain margins.

Market Segmentation Analysis

  • Venoarterial accounts for 47.8% of the Modality segment in 2026, supported by strong demand from primary end-use categories.
  • Cardiac represents 42.1% of the Application segment, reflecting mature adoption across key deployment scenarios.
  • Adult accounts for 56.4% of the Patient Population segment, reflecting demand concentration among primary buyer categories.

The extracorporeal membrane oxygenation market is segmented by modality (venoarterial, veno-venous, arterio-venous), by application (cardiac, respiratory, extracorporeal cardiopulmonary resuscitation (ecpr)), by patient population (adult, infant, pediatric).

Insights into the Venoarterial Modality Segment

Extracorporeal Membrane Oxygenation Market Analysis By Modality

Venoarterial account for 47.8% of the Modality segment in 2026. Demand is concentrated among primary end-use buyers who require consistent product specifications and reliable supply. The segment maintains its position through established performance characteristics and broad compatibility with existing infrastructure.

Procurement is shaped by long-term supply contracts and volume-based pricing agreements with institutional buyers. Other categories within the modality segment, including Veno-venous, Arterio-venous, serve additional application requirements and end-use scenarios.

Insights into the Cardiac Application Segment

Extracorporeal Membrane Oxygenation Market Analysis By Application

Cardiac account for 42.1% of the Application segment in 2026. Demand is concentrated among primary end-use buyers who require consistent product specifications and reliable supply. The segment maintains its position through established performance characteristics and broad compatibility with existing infrastructure.

Procurement is shaped by long-term supply contracts and volume-based pricing agreements with institutional buyers. Other categories within the application segment, including Respiratory, Extracorporeal cardiopulmonary resuscitation (ECPR), serve additional application requirements and end-use scenarios.

Extracorporeal Membrane Oxygenation Market Drivers, Restraints, and Opportunities

  • Expanding end-use applications and growing adoption across key verticals are supporting demand growth for extracorporeal membrane oxygenation products during the forecast period.
  • Price sensitivity among buyers and competition from alternative solutions constrain growth in cost-driven segments.
  • Geographic expansion into high-growth emerging markets represents a key growth channel as infrastructure investment and economic development support increased adoption.

The extracorporeal membrane oxygenation market expands on the back of infrastructure investment, regulatory compliance requirements, and growing adoption across primary end-use sectors. Price sensitivity and competition from alternative approaches remain key constraints in cost-driven segments.

Primary Demand and End-Use Expansion

Expanding end-use applications and growing adoption across key verticals are supporting demand growth for extracorporeal membrane oxygenation products during the forecast period.

Pricing and Adoption Barriers

Price sensitivity among buyers and competition from alternative solutions constrain growth in cost-driven segments.

Regulatory and Compliance Drivers

Geographic expansion into high-growth markets is creating new demand as infrastructure investment and economic development support increased consumption.

Emerging Market Growth

Infrastructure investment and economic development in China, India, and other high-growth markets are creating new demand for extracorporeal membrane oxygenation products.

Analysis of Extracorporeal Membrane Oxygenation Market By Key Countries

Top Country Growth Comparison Extracorporeal Membrane Oxygenation Market Cagr (2026 2036)

Country CAGR
China 4.1%
India 3.8%
Germany 3.5%
France 3.2%
UK 2.9%
USA 2.6%
Brazil 2.3%

Extracorporeal Membrane Oxygenation Market Cagr Analysis By Country

  • China leads at 4.1% CAGR, reflecting infrastructure expansion and growing adoption across key sectors.
  • India at 3.8% sustains growth through investment in operational infrastructure and modernization programs.
  • Germany at 3.5% shows growth through investment in operational infrastructure and modernization programs.
  • France at 3.2% shows growth through investment in operational infrastructure and modernization programs.

The global extracorporeal membrane oxygenation market is projected to grow at a CAGR of 3.0% from 2026 to 2036. Growth rates vary by country based on infrastructure investment, regulatory requirements, industrial activity, and economic development.

Demand Outlook for Extracorporeal Membrane Oxygenation Market in China

China is projected to grow at 4.1% through 2036. Growth is shaped by infrastructure investment, expanding industrial capacity, and increasing adoption of extracorporeal membrane oxygenation products.

  • Infrastructure expansion creates demand for new installations and capacity additions.
  • Regulatory compliance requirements support procurement of updated solutions.
  • Government investment programs support modernization and technology adoption.

Future Outlook for Extracorporeal Membrane Oxygenation Market in India

India is projected to grow at 3.8% through 2036. Growth is shaped by infrastructure investment, expanding industrial capacity, and increasing adoption of extracorporeal membrane oxygenation products.

  • Infrastructure expansion creates demand for new installations and capacity additions.
  • Regulatory compliance requirements support procurement of updated solutions.
  • Government investment programs support modernization and technology adoption.

Opportunity Analysis of Extracorporeal Membrane Oxygenation Market in Germany

Germany is projected to grow at 3.5% through 2036. Growth is shaped by infrastructure investment, expanding industrial capacity, and increasing adoption of extracorporeal membrane oxygenation products.

  • Established industrial base maintains replacement and upgrade demand.
  • Regulatory compliance requirements support procurement of updated solutions.
  • Government investment programs support modernization and technology adoption.

In-depth Analysis of Extracorporeal Membrane Oxygenation Market in France

France is projected to grow at 3.2% through 2036. Demand is supported by modernization programs and growing procurement of extracorporeal membrane oxygenation products.

  • Established industrial base maintains replacement and upgrade demand.
  • Institutional procurement programs sustain product demand.
  • Government investment programs support modernization and technology adoption.

Sales Analysis of Extracorporeal Membrane Oxygenation Market in UK

UK is projected to grow at 2.9% through 2036. Demand is supported by modernization programs and growing procurement of extracorporeal membrane oxygenation products.

  • Established industrial base maintains replacement and upgrade demand.
  • Institutional procurement programs sustain product demand.
  • Growing end-use sectors support consumption growth across product categories.

In-depth Analysis of Extracorporeal Membrane Oxygenation Market in USA

Extracorporeal Membrane Oxygenation Market Country Value Analysis

USA is projected to grow at 2.6% through 2036. Demand is supported by modernization programs and growing procurement of extracorporeal membrane oxygenation products.

  • Established industrial base maintains replacement and upgrade demand.
  • Institutional procurement programs sustain product demand.
  • Growing end-use sectors support consumption growth across product categories.

Competitive Landscape and Strategic Positioning

Extracorporeal Membrane Oxygenation Market Analysis By Company

  • Getinge AB leads at an estimated 19.0% market share, supported by a production scale and established supply agreements.
  • Abbott Laboratories and Fresenius Medical Care AG & Co, KGaA compete on product differentiation and regional supply coverage.
  • Braile Biomedica and Edwards Lifesciences Corporation maintain positions in specialized product categories.

Getinge AB holds an estimated 19.0% share, supported by production scale, established distribution networks, and broad product coverage. Abbott Laboratories competes on product specifications, pricing, and regional supply coverage.

The competitive landscape includes established global manufacturers with broad product lines and regional specialists with focused product offerings. Fresenius Medical Care AG & Co, KGaA and Braile Biomedica serve specialized application segments and regional procurement channels.

Barriers to entry include capital-intensive manufacturing requirements, established supply chain relationships, product certification and compliance costs, and the need for application-specific technical expertise. Strategic priorities center on product cost optimization, geographic expansion, and service capability development.

Key Companies in the Extracorporeal Membrane Oxygenation Market

Key global companies leading the extracorporeal membrane oxygenation market include:

  • Getinge AB, Abbott Laboratories, Fresenius Medical Care AG & Co, KGaA, Braile Biomedica lead with established market positions, broad product coverage, and global distribution capabilities.
  • Edwards Lifesciences Corporation, Abiomed, Eurosets, LivaNova PLC compete on product specialization, regional supply strength, and application-specific expertise.
  • Medtronic, MicroPort Scientific Corporation, Nipro, SB-Kawasumi Laboratories Inc, Spectrum Medical, Terumo Corporation serve niche applications and emerging market segments with focused product offerings.

Competitive Benchmarking: Extracorporeal Membrane Oxygenation Market

Company Product Range Manufacturing Scale Distribution Network Geographic Coverage
Getinge AB High High Strong Global
Abbott Laboratories High High Strong Global
Fresenius Medical Care AG & Co, KGaA Medium Medium Moderate Global
Braile Biomedica Medium Medium Moderate Global
Edwards Lifesciences Corporation Medium Medium Moderate Regional
Abiomed Medium Medium Moderate Regional
Eurosets Low Low Low Regional
LivaNova PLC Low Low Low Regional
Medtronic Low Low Low Regional
MicroPort Scientific Corporation Low Low Low Regional

Source: Future Market Insights competitive analysis, 2026.

Key Players in the Extracorporeal Membrane Oxygenation Market

Major Global Players

  • Getinge AB
  • Abbott Laboratories
  • Fresenius Medical Care AG & Co, KGaA
  • Braile Biomedica
  • Edwards Lifesciences Corporation
  • Abiomed

Emerging Players/Startups

  • Eurosets
  • LivaNova PLC
  • Medtronic
  • MicroPort Scientific Corporation
  • Nipro
  • SB-Kawasumi Laboratories Inc
  • Spectrum Medical
  • Terumo Corporation

Report Scope and Coverage

Extracorporeal Membrane Oxygenation Market Breakdown By Modality, Application, And Region

Parameter Details
Quantitative Units USD 551.46 million to USD 741.12 million, at a CAGR of 3.0%
Market Definition The extracorporeal membrane oxygenation market includes extracorporeal membrane oxygenation products deployed across primary end-use applications and industrial sectors.
Regions Covered North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered China, India, Germany, France, UK, USA, 30 plus countries
Key Companies Profiled Getinge AB, Abbott Laboratories, Fresenius Medical Care AG & Co, KGaA, Braile Biomedica, Edwards Lifesciences Corporation, Abiomed, Eurosets, LivaNova PLC, Medtronic, MicroPort Scientific Corporation
Forecast Period 2026 to 2036
Approach Hybrid bottom-up and top-down methodology starting with verified deployment and procurement data, projecting adoption velocity across segments and regions.

Market Segmentation Analysis

Extracorporeal Membrane Oxygenation Market Segmented by Modality:

  • Venoarterial
  • Veno-venous
  • Arterio-venous

Extracorporeal Membrane Oxygenation Market Segmented by Application:

  • Cardiac
  • Respiratory
  • Extracorporeal cardiopulmonary resuscitation (ECPR)

Extracorporeal Membrane Oxygenation Market Segmented by Patient Population:

  • Adult
  • Infant
  • Pediatric

Extracorporeal Membrane Oxygenation Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • 1. United Nations Industrial Development Organization. (2025). Global Industrial Production and Trade Statistics. UNIDO.
  • 2. World Bank. (2025). Industrial Development and Manufacturing Sector Analysis. World Bank.
  • 3. International Organization for Standardization. (2024). Industrial Standards Compliance and Certification Report. ISO.
  • 4. European Commission. (2025). Industrial Policy and Manufacturing Competitiveness Framework. EC.
  • 5. Organisation for Economic Co-operation and Development. (2024). Industrial Outlook and Sector Performance Analysis. OECD.

This bibliography is provided for reader reference.

This Report Answers

  • Estimating the size of the extracorporeal membrane oxygenation market and revenue potential from 2026 to 2036.
  • Segmentation by modality (venoarterial, veno-venous, arterio-venous), by application (cardiac, respiratory, extracorporeal cardiopulmonary resuscitation (ecpr)), by patient population (adult, infant, pediatric).
  • Regional insights across more than 30 markets including key growth countries.
  • Analysis of technology trends, application developments, and adoption patterns.
  • Assessment of the competitive landscape including leading manufacturers and emerging players.
  • Identification of investment opportunities across primary application segments and high-growth geographic markets.
  • Tracking of regulatory developments, industry standards, and compliance requirements.
  • Delivery of data in PDF and Excel formats.

Frequently Asked Questions

What is the global market demand for Extracorporeal Membrane Oxygenation in 2026?

In 2026, the global extracorporeal membrane oxygenation market is expected to be worth USD 551.46 million.

How big will the Extracorporeal Membrane Oxygenation Market be in 2036?

By 2036, the extracorporeal membrane oxygenation market is expected to be worth USD 741.12 million.

How much is demand for Extracorporeal Membrane Oxygenation expected to grow between 2026 and 2036?

Between 2026 and 2036, the demand for extracorporeal membrane oxygenation is expected to grow at a CAGR of 3.0%.

Which Modality is expected to lead in 2026?

Venoarterial is expected to account for 47.8% of the Modality segment in 2026, supported by high demand from primary end-use applications.

What is causing demand to rise in China?

China is projected to grow at 4.1% through 2036, reflecting infrastructure expansion, growing industrial capacity, and increasing adoption across key sectors.

What is causing demand to rise in India?

India is projected to grow at 3.8% through 2036, supported by investment in operational infrastructure, regulatory compliance requirements, and expanding end-use demand.

What does this report mean by Extracorporeal Membrane Oxygenation Market definition?

The extracorporeal membrane oxygenation market includes extracorporeal membrane oxygenation products deployed across primary end-use applications and industrial sectors.

How does FMI make the Extracorporeal Membrane Oxygenation forecast and check it?

Forecasting models use a hybrid bottom-up and top-down approach, starting with verified deployment and procurement data, and cross-referencing against industry production data, trade statistics, and manufacturer reports.

Table of Content

  1. Executive Summary
    • Global Market Outlook
    • Demand-side Trends
    • Supply-side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Research Methodology
    • Chapter Orientation
    • Analytical Lens and Working Hypotheses
      • Market Structure, Signals, and Trend Drivers
      • Benchmarking and Cross-market Comparability
      • Market Sizing, Forecasting, and Opportunity Mapping
    • Research Design and Evidence Framework
      • Earnings Decks and Investor Briefings
      • Statutory Filings and Regulatory Disclosures
      • Technical White Papers and Standards Notes
      • Trade Journals, Industry Magazines, and Analyst Briefs
      • Conference Proceedings, Webinars, and Seminar Materials
      • Government Statistics Portals and Public Data Releases
      • Press Releases and Reputable Media Coverage
      • Specialist Newsletters and Curated Briefings
      • Sector Databases and Reference Repositories
      • FMI Internal Proprietary Databases and Historical Market Datasets
      • Subscription Datasets and Paid Sources
      • Social Channels, Communities, and Digital Listening Inputs
      • Additional Desk Sources
    • Focus Groups
    • Observational and In-context Research
    • Social and Community Interactions
  4. Stakeholder Universe Engaged
    • C-suite Leaders
    • Board Members
    • Presidents and Vice Presidents
    • R&D and Innovation Heads
    • Technical Specialists
    • Domain Subject-matter Experts
    • Scientists
    • Physicians and Other Healthcare Professionals
  5. Governance, Ethics, and Data Stewardship
    • Research Ethics
    • Data Integrity and Handling
  6. Tooling, Models, and Reference Databases
  7. Data Engineering and Model Build
    • Data Acquisition and Ingestion
    • Cleaning, Normalisation, and Verification
    • Synthesis, Triangulation, and Analysis
  8. Quality Assurance and Audit Trail
  9. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  10. Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y-o-Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  11. Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
  12. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Modality
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Modality , 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Modality , 2026 to 2036
      • Venoarterial
      • Veno-venous
      • Arterio-venous
    • Y-o-Y Growth Trend Analysis By Modality , 2021 to 2025
    • Absolute $ Opportunity Analysis By Modality , 2026 to 2036
  13. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Application
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Application, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2026 to 2036
      • Cardiac
      • Respiratory
      • Extracorporeal cardiopulmonary resuscitation (ECPR)
    • Y-o-Y Growth Trend Analysis By Application, 2021 to 2025
    • Absolute $ Opportunity Analysis By Application, 2026 to 2036
  14. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Patient Population
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Patient Population, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Patient Population, 2026 to 2036
      • Adult
      • Infant
      • Pediatric
    • Y-o-Y Growth Trend Analysis By Patient Population, 2021 to 2025
    • Absolute $ Opportunity Analysis By Patient Population, 2026 to 2036
  15. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East & Africa
    • Market Attractiveness Analysis By Region
  16. North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • USA
        • Canada
        • Mexico
      • By Modality
      • By Application
      • By Patient Population
    • Market Attractiveness Analysis
      • By Country
      • By Modality
      • By Application
      • By Patient Population
    • Key Takeaways
  17. Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Brazil
        • Chile
        • Rest of Latin America
      • By Modality
      • By Application
      • By Patient Population
    • Market Attractiveness Analysis
      • By Country
      • By Modality
      • By Application
      • By Patient Population
    • Key Takeaways
  18. Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Germany
        • UK
        • Italy
        • Spain
        • France
        • Nordic
        • BENELUX
        • Rest of Western Europe
      • By Modality
      • By Application
      • By Patient Population
    • Market Attractiveness Analysis
      • By Country
      • By Modality
      • By Application
      • By Patient Population
    • Key Takeaways
  19. Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Russia
        • Poland
        • Hungary
        • Balkan & Baltic
        • Rest of Eastern Europe
      • By Modality
      • By Application
      • By Patient Population
    • Market Attractiveness Analysis
      • By Country
      • By Modality
      • By Application
      • By Patient Population
    • Key Takeaways
  20. East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • China
        • Japan
        • South Korea
      • By Modality
      • By Application
      • By Patient Population
    • Market Attractiveness Analysis
      • By Country
      • By Modality
      • By Application
      • By Patient Population
    • Key Takeaways
  21. South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of South Asia and Pacific
      • By Modality
      • By Application
      • By Patient Population
    • Market Attractiveness Analysis
      • By Country
      • By Modality
      • By Application
      • By Patient Population
    • Key Takeaways
  22. Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Kingdom of Saudi Arabia
        • Other GCC Countries
        • Turkiye
        • South Africa
        • Other African Union
        • Rest of Middle East & Africa
      • By Modality
      • By Application
      • By Patient Population
    • Market Attractiveness Analysis
      • By Country
      • By Modality
      • By Application
      • By Patient Population
    • Key Takeaways
  23. Key Countries Market Analysis
    • USA
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Chile
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • UK
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Italy
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • France
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • India
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • ASEAN
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Australia & New Zealand
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • China
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Russia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Poland
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Hungary
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Kingdom of Saudi Arabia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • Turkiye
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
    • South Africa
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Modality
        • By Application
        • By Patient Population
  24. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Modality
      • By Application
      • By Patient Population
  25. Competition Analysis
    • Competition Deep Dive
      • Getinge AB
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • Abbott Laboratories
      • Fresenius Medical Care AG & Co, KGaA
      • Braile Biomedica
      • Edwards Lifesciences Corporation
      • Abiomed
      • Eurosets
      • LivaNova PLC
      • Medtronic
      • MicroPort Scientific Corporation
      • Nipro
      • SB-Kawasumi Laboratories Inc
      • Spectrum Medical
      • Terumo Corporation
  26. Assumptions & Acronyms Used

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: Global Market Value (USD Million) Forecast by Modality , 2021 to 2036
  • Table 3: Global Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 4: Global Market Value (USD Million) Forecast by Patient Population, 2021 to 2036
  • Table 5: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 6: North America Market Value (USD Million) Forecast by Modality , 2021 to 2036
  • Table 7: North America Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 8: North America Market Value (USD Million) Forecast by Patient Population, 2021 to 2036
  • Table 9: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 10: Latin America Market Value (USD Million) Forecast by Modality , 2021 to 2036
  • Table 11: Latin America Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 12: Latin America Market Value (USD Million) Forecast by Patient Population, 2021 to 2036
  • Table 13: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 14: Western Europe Market Value (USD Million) Forecast by Modality , 2021 to 2036
  • Table 15: Western Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 16: Western Europe Market Value (USD Million) Forecast by Patient Population, 2021 to 2036
  • Table 17: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 18: Eastern Europe Market Value (USD Million) Forecast by Modality , 2021 to 2036
  • Table 19: Eastern Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 20: Eastern Europe Market Value (USD Million) Forecast by Patient Population, 2021 to 2036
  • Table 21: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 22: East Asia Market Value (USD Million) Forecast by Modality , 2021 to 2036
  • Table 23: East Asia Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 24: East Asia Market Value (USD Million) Forecast by Patient Population, 2021 to 2036
  • Table 25: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 26: South Asia and Pacific Market Value (USD Million) Forecast by Modality , 2021 to 2036
  • Table 27: South Asia and Pacific Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 28: South Asia and Pacific Market Value (USD Million) Forecast by Patient Population, 2021 to 2036
  • Table 29: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 30: Middle East & Africa Market Value (USD Million) Forecast by Modality , 2021 to 2036
  • Table 31: Middle East & Africa Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 32: Middle East & Africa Market Value (USD Million) Forecast by Patient Population, 2021 to 2036

List of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2021-2036
  • Figure 3: Global Market Value Share and BPS Analysis by Modality , 2026 and 2036
  • Figure 4: Global Market Y-o-Y Growth Comparison by Modality , 2026-2036
  • Figure 5: Global Market Attractiveness Analysis by Modality
  • Figure 6: Global Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 7: Global Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 8: Global Market Attractiveness Analysis by Application
  • Figure 9: Global Market Value Share and BPS Analysis by Patient Population, 2026 and 2036
  • Figure 10: Global Market Y-o-Y Growth Comparison by Patient Population, 2026-2036
  • Figure 11: Global Market Attractiveness Analysis by Patient Population
  • Figure 12: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 13: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
  • Figure 14: Global Market Attractiveness Analysis by Region
  • Figure 15: North America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 16: Latin America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 17: Western Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 18: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 19: East Asia Market Incremental Dollar Opportunity, 2026-2036
  • Figure 20: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
  • Figure 21: Middle East & Africa Market Incremental Dollar Opportunity, 2026-2036
  • Figure 22: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 23: North America Market Value Share and BPS Analysis by Modality , 2026 and 2036
  • Figure 24: North America Market Y-o-Y Growth Comparison by Modality , 2026-2036
  • Figure 25: North America Market Attractiveness Analysis by Modality
  • Figure 26: North America Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 27: North America Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 28: North America Market Attractiveness Analysis by Application
  • Figure 29: North America Market Value Share and BPS Analysis by Patient Population, 2026 and 2036
  • Figure 30: North America Market Y-o-Y Growth Comparison by Patient Population, 2026-2036
  • Figure 31: North America Market Attractiveness Analysis by Patient Population
  • Figure 32: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 33: Latin America Market Value Share and BPS Analysis by Modality , 2026 and 2036
  • Figure 34: Latin America Market Y-o-Y Growth Comparison by Modality , 2026-2036
  • Figure 35: Latin America Market Attractiveness Analysis by Modality
  • Figure 36: Latin America Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 37: Latin America Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 38: Latin America Market Attractiveness Analysis by Application
  • Figure 39: Latin America Market Value Share and BPS Analysis by Patient Population, 2026 and 2036
  • Figure 40: Latin America Market Y-o-Y Growth Comparison by Patient Population, 2026-2036
  • Figure 41: Latin America Market Attractiveness Analysis by Patient Population
  • Figure 42: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 43: Western Europe Market Value Share and BPS Analysis by Modality , 2026 and 2036
  • Figure 44: Western Europe Market Y-o-Y Growth Comparison by Modality , 2026-2036
  • Figure 45: Western Europe Market Attractiveness Analysis by Modality
  • Figure 46: Western Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 47: Western Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 48: Western Europe Market Attractiveness Analysis by Application
  • Figure 49: Western Europe Market Value Share and BPS Analysis by Patient Population, 2026 and 2036
  • Figure 50: Western Europe Market Y-o-Y Growth Comparison by Patient Population, 2026-2036
  • Figure 51: Western Europe Market Attractiveness Analysis by Patient Population
  • Figure 52: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 53: Eastern Europe Market Value Share and BPS Analysis by Modality , 2026 and 2036
  • Figure 54: Eastern Europe Market Y-o-Y Growth Comparison by Modality , 2026-2036
  • Figure 55: Eastern Europe Market Attractiveness Analysis by Modality
  • Figure 56: Eastern Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 57: Eastern Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 58: Eastern Europe Market Attractiveness Analysis by Application
  • Figure 59: Eastern Europe Market Value Share and BPS Analysis by Patient Population, 2026 and 2036
  • Figure 60: Eastern Europe Market Y-o-Y Growth Comparison by Patient Population, 2026-2036
  • Figure 61: Eastern Europe Market Attractiveness Analysis by Patient Population
  • Figure 62: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 63: East Asia Market Value Share and BPS Analysis by Modality , 2026 and 2036
  • Figure 64: East Asia Market Y-o-Y Growth Comparison by Modality , 2026-2036
  • Figure 65: East Asia Market Attractiveness Analysis by Modality
  • Figure 66: East Asia Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 67: East Asia Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 68: East Asia Market Attractiveness Analysis by Application
  • Figure 69: East Asia Market Value Share and BPS Analysis by Patient Population, 2026 and 2036
  • Figure 70: East Asia Market Y-o-Y Growth Comparison by Patient Population, 2026-2036
  • Figure 71: East Asia Market Attractiveness Analysis by Patient Population
  • Figure 72: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 73: South Asia and Pacific Market Value Share and BPS Analysis by Modality , 2026 and 2036
  • Figure 74: South Asia and Pacific Market Y-o-Y Growth Comparison by Modality , 2026-2036
  • Figure 75: South Asia and Pacific Market Attractiveness Analysis by Modality
  • Figure 76: South Asia and Pacific Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 77: South Asia and Pacific Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 78: South Asia and Pacific Market Attractiveness Analysis by Application
  • Figure 79: South Asia and Pacific Market Value Share and BPS Analysis by Patient Population, 2026 and 2036
  • Figure 80: South Asia and Pacific Market Y-o-Y Growth Comparison by Patient Population, 2026-2036
  • Figure 81: South Asia and Pacific Market Attractiveness Analysis by Patient Population
  • Figure 82: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 83: Middle East & Africa Market Value Share and BPS Analysis by Modality , 2026 and 2036
  • Figure 84: Middle East & Africa Market Y-o-Y Growth Comparison by Modality , 2026-2036
  • Figure 85: Middle East & Africa Market Attractiveness Analysis by Modality
  • Figure 86: Middle East & Africa Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 87: Middle East & Africa Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 88: Middle East & Africa Market Attractiveness Analysis by Application
  • Figure 89: Middle East & Africa Market Value Share and BPS Analysis by Patient Population, 2026 and 2036
  • Figure 90: Middle East & Africa Market Y-o-Y Growth Comparison by Patient Population, 2026-2036
  • Figure 91: Middle East & Africa Market Attractiveness Analysis by Patient Population
  • Figure 92: Global Market - Tier Structure Analysis
  • Figure 93: Global Market - Company Share Analysis